ArticleClinical transplantation and research2026
West Nile virus encephalitis in a kidney transplant recipient: a case report and review of the literature.
Article in Clinical transplantation and research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
West Nile virus (WNV) neuroinvasive disease is an uncommon but serious complication in solid organ transplant (SOT) recipients. We report the case of a 66‑year‑old kidney transplant recipient who developed encephalitis during the 2024 mosquito season in South Carolina. The patient presented with high‑grade fever and progressive altered mental status. Brain magnetic resonance imaging showed symmetric posterior fluid-attenuated inversion recovery hyperintensities, and tacrolimus‑associated posterior reversible encephalopathy syndrome was suspected. However, cerebrospinal fluid analysis revealed lymphocytic pleocytosis and was ultimately positive for WNV immunoglobulin M, immunoglobulin G, and polymerase chain reaction, confirming neuroinvasive infection. Immunosuppression was reduced, and a 5‑day course of intravenous immunoglobulin (IVIG) was administered. The patient's neurological status gradually improved; however, allograft function deteriorated, and long‑term hemodialysis became necessary. At 6‑month follow‑up, the patient remained on dialysis and was dependent on others for activities of daily living. This case highlights diagnostic challenges in immunosuppressed hosts, emphasizes the importance of vector-borne infection surveillance in SOT populations, and supports immunosuppression reduction with adjunctive IVIG as a reasonable therapeutic approach. Routine WNV screening of donors in endemic areas and patient education on mosquito avoidance may help mitigate risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.